{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T16:58:22Z","timestamp":1785344302893,"version":"3.55.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Concerns about potential associations between measles\u2013mumps\u2013rubella (MMR) vaccination and autism persist despite extensive prior research. Observational studies evaluating vaccine timing are susceptible to bias from healthcare utilization patterns, neurodevelopmental concerns and time-dependent exposure classification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study using the Cosmos electronic health record database, including 2,560,035 US children with linked birth-parent data and follow-up through age 8 years. To minimize bias related to exposure timing and healthcare utilization, we performed prespecified age-based landmark analyses evaluating the first MMR vaccination administered between 11.5 and 24 months. Adjusted hazard ratios (aHRs) for autism were estimated using Cox proportional hazards models with covariates selected via directed acyclic graphs. A negative control exposure (pneumococcal conjugate vaccine booster administered at 12\u201315 months) was analyzed to assess residual confounding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In the primary 11.5\u201324 month landmark cohort, the first MMR vaccination was not associated with increased autism risk (aHR 0.97; 99% confidence interval 0.91\u20131.03). Across all age-specific landmark cohorts, aHRs remained near the null. The negative control analysis yielded a similarly near-null estimate (aHR 1.01; 99% confidence interval 0.99\u20131.04), supporting that residual bias is unlikely to explain the findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In this large US cohort, age-anchored landmark analyses show no association between MMR vaccination before 24 months and childhood autism. The concordant near-null findings for both MMR and a negative control exposure support that the observed results are unlikely to be explained by residual confounding. These findings highlight the importance of age-specific analytic approaches in evaluating vaccine safety using observational data.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000005349","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T20:00:13Z","timestamp":1785268813000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Association Between First MMR Vaccination Before Age 2 Years and Childhood Autism in a U.S. EHR Cohort of 2.5 Million Children"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7290-6323","authenticated-orcid":false,"given":"Todd L.","family":"Burstain","sequence":"first","affiliation":[{"name":"University of Washington Medicine, Seattle, Washington State"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale","family":"Jacques","sequence":"additional","affiliation":[{"name":"University of Washington, Alumni, Seattle, Washington State."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2699-3483","authenticated-orcid":false,"given":"Jennifer M.","family":"Burstain","sequence":"additional","affiliation":[{"name":"University of Washington, Alumni, Seattle, Washington State."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"R1-20260729","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss7202a1","article-title":"Prevalence and characteristics of autism spectrum disorder among children aged 8 years\u2014autism and developmental disabilities monitoring network, 11 sites, United States, 2020.","volume":"72","author":"Maenner","year":"2023","journal-title":"MMWR Surveill Summ"},{"key":"R2-20260729","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/jcpp.12941","article-title":"Editorial: the rising prevalence of autism.","volume":"59","author":"Fombonne","year":"2018","journal-title":"J Child Psychol Psychiatry"},{"key":"R3-20260729","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1016\/j.vaccine.2015.04.036","article-title":"Vaccine hesitancy: definition, scope and determinants.","volume":"33","author":"MacDonald","year":"2015","journal-title":"Vaccine"},{"key":"R4-20260729","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0140-6736(10)60175-4","article-title":"Retraction--Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.","volume":"375","author":"Horton","year":"2010","journal-title":"Lancet"},{"key":"R5-20260729","doi-asserted-by":"crossref","first-page":"513","DOI":"10.7326\/M18-2101","article-title":"Measles, mumps, rubella vaccination and autism: a nationwide cohort study.","volume":"170","author":"Hviid","year":"2019","journal-title":"Ann Intern Med"},{"key":"R6-20260729","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0140-6736(99)01239-8","article-title":"Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association.","volume":"353","author":"Taylor","year":"1999","journal-title":"Lancet"},{"key":"R7-20260729","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1001\/jama.2015.3077","article-title":"Autism occurrence by MMR vaccine status among US children with older siblings with and without autism.","volume":"313","author":"Jain","year":"2015","journal-title":"JAMA"},{"key":"R12-20260729","first-page":"CD004407","article-title":"Vaccines for measles, mumps, rubella, and varicella in children.","volume":"11","author":"Di Pietrantonj","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"R13-20260729","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/pds.1357","article-title":"Immortal time bias in observational studies of drug effects.","volume":"16","author":"Suissa","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R14-20260729","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available.","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol"},{"key":"R15-20260729","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00001648-199901000-00008","article-title":"Causal diagrams for epidemiologic research.","volume":"10","author":"Greenland","year":"1999","journal-title":"Epidemiology"},{"key":"R17-20260729","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/1362361312467709","article-title":"Does a claims diagnosis of autism mean a true case?","volume":"18","author":"Burke","year":"2014","journal-title":"Autism"},{"key":"R20-20260729","doi-asserted-by":"crossref","first-page":"e2429434","DOI":"10.1001\/jamanetworkopen.2024.29434","article-title":"Maternal characteristics and prevalence of infants born small for gestational age.","volume":"7","author":"Xiang","year":"2024","journal-title":"JAMA Netw Open"},{"key":"R21-20260729","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2147\/CLEP.S44408","article-title":"Positive predictive value of the infant respiratory distress syndrome diagnosis in the Danish national patient registry.","volume":"5","author":"Thygesen","year":"2013","journal-title":"Clin Epidemiol"},{"key":"R24-20260729","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/pds.5633","article-title":"Distribution of gestational age at birth by maternal and infant characteristics in U.S. birth certificate data: Informing gestational age assumptions when clinical estimates are not available.","volume":"32","author":"Margulis","year":"2023","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R25-20260729","first-page":"1","article-title":"Apgar scores reported on U.S. live births, 1978.","volume":"30","year":"1981","journal-title":"Mon Vital Stat Rep"},{"key":"R26-20260729","article-title":"Births: final data for 2023.","volume":"74","year":"2025","journal-title":"Natl Vital Stat Rep"},{"key":"R27-20260729","first-page":"1","article-title":"Births: final Data for 2023.","volume":"74","author":"Osterman","year":"2024","journal-title":"Natl Vital Stat Rep"},{"key":"R28-20260729","doi-asserted-by":"crossref","first-page":"16","DOI":"10.15585\/mmwr.mm7201a4","article-title":"QuickStats: percentage of mothers with gestational diabetes, by maternal age \u2014 national vital statistics system, United States, 2016 and 2021.","volume":"72","author":"Dillinger","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R29-20260729","doi-asserted-by":"crossref","first-page":"18","DOI":"10.15585\/mmwr.mm6701a4","article-title":"Antibiotics dispensed to privately insured pregnant women with urinary tract infections - United States, 2014.","volume":"67","author":"Ailes","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005349","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T16:00:13Z","timestamp":1785340813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":20,"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005349","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]}}}